PH vs ZKIN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

PH

34.0
AI Score
VS
ZKIN Wins

ZKIN

51.4
AI Score

Investment Advisor Scores

PH

34score
Recommendation
SELL

ZKIN

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PH ZKIN Winner
Revenue 19.85B 71.24M PH
Net Income 3.53B -3.99M PH
Net Margin 17.8% -5.6% PH
Operating Income 4.35B -4.25M PH
ROE 25.8% -16.3% PH
ROA 12.0% -6.3% PH
Total Assets 29.49B 62.87M PH
Cash 467.00M 2.31M PH
Current Ratio 1.19 1.44 ZKIN
Free Cash Flow 3.34B 147,846 PH

Relative Price Performance (Last 90 Days)

PH 1M: +1.6% · 3M: +15.8% ZKIN 1M: -20.4% · 3M: -25.0%

Current Technical Phase

PH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.1 · Price: $1001.74

ZKIN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.0%), weak momentum, RSI 45

RSI (14): 44.9 · Price: $1.11

Fundamentals Snapshot

Metric PH ZKIN
Market Cap
Forward P/E 29.2 0.0
Trailing P/E 36.6
Revenue (TTM)
Revenue Growth 0.1% -0.4%
Gross Margin 0.4% 0.1%
Operating Margin 0.2% -0.1%
EPS 27.93 -0.71
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, ZKIN is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.